# US 2024/0366766 A1 · Polymer compound for surface modification to enhance anticancer immune function of natural killer cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0366766 A1
- Document ID: US20240366766A1
- Status: Published application
- Kind: A1
- Application number: 18/641,336
- Filed: 2024-04-20
- Published: 2024-11-07
- Earliest claimed: 2021-10-22
- Assignees: Dongguk University Industry-Academic Cooperation Foundation
- Applicants: Dongguk University Industry-Academic Cooperation Foundation
- Inventors: Kyobum KIM; Sungjun KIM; Gajendiran MANI
- Web page: https://patentgrep.com/patent/US20240366766A1

## CPC

- A61K 47/32: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone}
- A61K 35/17: Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes (when activated by a specific antigen A61K39/00)
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/183: {Amino acids, e.g. glycine, EDTA or aspartame}
- A61P 35/00: Antineoplastic agents
- C08G 75/14: Polysulfides
- C08G 79/04: Phosphorus linked to oxygen or to oxygen and carbon
- C08L 81/00: Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing sulfur with or without nitrogen, oxygen or carbon only; Compositions of polysulfones; Compositions of derivatives of such polymers
- C08L 81/10: Polysulfonamides; Polysulfonimides
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

Provided relates to a polymer compound and a method for preparing same, the polymer compound comprising: a hydrophobic moiety that binds to natural killer cells; a cancer cell recognition moiety; and a linker, wherein the hydrophobic moiety is bound to one end of the linker, and the cancer cell recognition moiety is bound to the other end of the linker, thus recognizing natural killer cells and cancer cells.

## Claims

### Claim 1

A polymer compound characterized by comprising: a hydrophobic moiety binding to natural killer cells; a cancer cell recognition moiety; and a linker comprising the structure of Chemical formula 1, wherein the hydrophobic moiety is bound to one end of the linker, and wherein the cancer cell recognition moiety is bound to the other end of the linker, thereby forming a polymer compound capable of recognizing natural killer cells and cancer cells,
wherein, the variable “n” is an integer ranging from 30 to 50.

### Claim 2 (depends on 1)

The polymer compound recognizing natural killer cells and cancer cells according to claim 1, wherein the hydrophobic moiety binds to natural killer cells, and said cancer cell recognition moiety recognizes cancer cells, thereby promoting apoptosis of cancer cells.

### Claim 3 (depends on 1)

The polymer compound recognizing natural killer cells and cancer cells according to claim 1, wherein the hydrophobic moiety binding to the natural killer cells comprises a lipid with an alkyl chain containing 12 to 24 carbon atoms; a sterol lipid with 10 to 30 carbon atoms; 1,2-bis(diphenylphosphino)ethane (DPPE); or 1,2-bis (dimethylphosphino)ethane (DMPE).

### Claim 4 (depends on 1)

The polymer compound recognizing natural killer cells and cancer cells according to claim 1, wherein the cancer cell-targeting moiety comprises one or more selected from the group consisting of folic acid, biotin, phenylboronic acid, and phenylboronic acid.

### Claim 5 (depends on 1)

The polymer compound recognizing natural killer cells and cancer cells according to claim 1, wherein a polymer compound recognizing natural killer cells and cancer cells, comprising a linker incorporating a compound for intracellular trafficking prevention, one or more cationic amino acids, and a fluorescent dye compound, all of which are associated with the structure of chemical formula 1.

### Claim 6 (depends on 5)

The polymer compound recognizing natural killer cells and cancer cells according to claim 5, wherein the compound for intracellular trafficking prevention, as described above, is selected from the group consisting of polyethylene glycol (PEG), polyethylene oxide (PEO), polyvinyl alcohol (PVA), and their copolymers.

### Claim 7 (depends on 5)

The polymer compound recognizing natural killer cells and cancer cells according to claim 5, wherein the cationic amino acid is selected from the group consisting of arginine, lysine, and histidine.

### Claim 8

A preparation method of a polymer compound recognizing natural killer cells and cancer cells, the method comprising: (a) providing a compound represented by the following chemical formula 3 by coupling a compound represented by the chemical formula 2 to one end of a compound represented by the following chemical formula 1; and (b) a step of coupling an cancer cell recognition moiety to the other end of a compound represented by the chemical formula 3,
wherein, the variable n is an integer ranging from 30 to 50, and the variable X represents one or more selected from acetyl, trifluoroacetyl, t-butoxycarbonyl (BOC), benzylcarbonyl (CBZ), and 9-fluorenylmethoxycarbonyl (Fmoc). Additionally, p is a natural number ranging from 12 to 20, and q is a natural number ranging from 12 to 20.

### Claim 9 (depends on 8)

A preparation method of a polymer compound recognizing natural killer cells and cancer cells according to claim 8, wherein the method for producing a polymer compound that recognizes natural killer cells and cancer cells, further comprising the step of substituting X with one of a compound for preventing cellular internalization, cationic amino acids, or fluorescent dye compounds.

### Claim 10 (depends on 8)

A preparation method of a polymer compound recognizing natural killer cells and cancer cells according to claim 8, wherein the cancer cell recognition moiety is selected from a group consisting of folic acid, biotin, phenylboronic acid, and phenylboronic acid.

### Claim 11 (depends on 8)

A preparation method of a polymer compound recognizing natural killer cells and cancer cells according to claim 8, wherein the cell internalization prevention compound is selected from a group consisting of polyethylene glycol (PEG), polyethylene oxide (PEO), and their copolymers.

### Claim 12 (depends on 8)

A preparation method of a polymer compound recognizing natural killer cells and cancer cells according to claim 8, wherein the cationic amino acid is selected from a group consisting of arginine, lysine, and histidine.

### Claim 13 (depends on 8)

The polymer compound recognizing natural killer cells and cancer cells, manufactured through the method according to claim 8.

### Claim 14 (depends on 9)

The polymer compound recognizing natural killer cells and cancer cells, manufactured through the method according to claim 9.

### Claim 15

The pharmaceutical composition for preventing or treating cancer including a polymer compound characterized by comprising: a hydrophobic moiety binding to natural killer cells; a cancer cell recognition moiety; and a linker comprising the structure of Chemical formula 1, wherein the hydrophobic moiety is bound to one end of the linker, and wherein the cancer cell recognition moiety is bound to the other end of the linker, thereby forming a polymer compound capable of recognizing natural killer cells and cancer cells,
wherein the variable “n” is an integer ranging from 30 to 50.

### Claim 16 (depends on 15)

The pharmaceutical composition for preventing or treating cancer according to claim 15, wherein the diseases for which the anticancer effect is achieved by the pharmaceutical composition include, but are not limited to, prostate cancer, thyroid cancer, stomach cancer, colorectal cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, testicular cancer, oral cancer, basal cell carcinoma, brain tumor, gallbladder cancer, bile duct cancer, laryngeal cancer, retinoblastoma, Burkitt's lymphoma, bladder cancer, peritoneal cancer, adrenal cancer, non-small cell lung cancer, esophageal cancer, renal pelvis and ureter cancer, kidney cancer, malignant bone tumors, malignant soft tissue tumors, malignant lymphoma, malignant melanoma, eye tumor, urethral cancer, gastric cancer, melanoma, cervical cancer, endometrial cancer, uterine fibroids, metastatic brain tumors, colorectal cancer, vaginal cancer, spinal tumor, salivary gland cancer, tonsil cancer, squamous cell carcinoma, blood cancer, and anal cancer.

### Claim 17 (depends on 15)

The pharmaceutical composition for preventing or treating cancer according to claim 15, wherein the composition further comprises pharmaceutically acceptable carriers, excipients, or diluents.

### Claim 18 (depends on 15)

The method for treating cancer according to claim 15, where in the comprising administering to a subject a pharmaceutical composition.

### Claim 19 (depends on 16)

The method for treating cancer according to claim 16, where in the comprising administering to a subject a pharmaceutical composition.

### Claim 20 (depends on 17)

The method for treating cancer according to claim 17, where in the comprising administering to a subject a pharmaceutical composition.
